Creo Medical Group PLC CREO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- GBX10.88
- Day Range
- GBX10.50–11.00
- 52-Week Range
- GBX9.50–18.50
- Bid/Ask
- GBX0.00 / GBX0.00
- Shares Outstanding
- 449.14M
- Market Cap
- GBX4.77B
- Volume/Avg
- 948,450 / 703,566
Key Statistics
- Price/Earnings (Normalized)
- 13.30
- Price/Sales
- 6.46
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy. Geographically, the company generates a majority of its revenue from United Kingdom and the rest from Europe and the rest of the world.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 104
- Website
- https://www.creomedical.com
Valuation
Metric | CREO |
|---|---|
Price/Earnings (Normalized) | 13.30 |
Price/Book Value | 1.41 |
Price/Sales | 6.46 |
Price/Cash Flow | — |
Price/Earnings
CREO
Financial Strength
Metric | CREO |
|---|---|
Quick Ratio | 2.33 |
Current Ratio | 2.79 |
Interest Coverage | −39.50 |
Quick Ratio
CREO
Profitability
Metric | CREO |
|---|---|
Return on Assets (Normalized) | −23.55% |
Return on Equity (Normalized) | −36.22% |
Return on Invested Capital (Normalized) | −25.22% |
Return on Assets
CREO
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|>rTR!V^ | LOCK|QtJPz | $197B | |||
| Medtronic PLC MDT | LOCK|Mq@%h!^ | LOCK|fdwq | $134B | |||
| Stryker Corp SYK | LOCK|R<l!hhL | LOCK|n& | $128B | |||
| Boston Scientific Corp BSX | LOCK|s?P>Jlf | LOCK|W>?L | $65B | |||
| Edwards Lifesciences Corp EW | LOCK|WRJ@n?@% | LOCK|ZP>R! | $58B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|nRHz%< | LOCK|^S | $38B | |||
| DexCom Inc DXCM | LOCK|Tq@d$>% | LOCK|xX!< | $31B | |||
| Koninklijke Philips NV ADR PHG | LOCK|ZfZ | LOCK|s@r | $30B | |||
| Steris PLC STE | LOCK|WLyCSxX | LOCK|cy><G | $25B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|j&@TS@G# | LOCK|dTy | $20B |
United States